Metagenomi, Inc. Common Stock (MGX)
Healthcare
- Fundamental
- 2
- Sentiment
- 2
- Technical
- 1
Do Nothing: core technical indicator feed failed to load, so the chart read is unreliable and no trade can be scored.
Company overview
Metagenomi, Inc. is a biotechnology company specializing in gene editing to develop therapeutic solutions. The company uses a genome editing toolkit derived from metagenomics, including programmable nucleases and CRISPR-associated transposases. It has partnerships with ModernaTX, Affini-T Therapeutics, and Ionis Pharmaceuticals for various gene-editing applications.
Fundamental
weakMetagenomi has liquidity but faces speculative fundamentals with high cash burn and clinical execution risks.
Metagenomi is a cash-backed, early-stage gene-editing biotech with runway disclosed into late 2027, but it remains deeply unprofitable with heavy cash burn and highly variable collaboration revenue. The balance sheet reduces near-term solvency risk, yet the investment case is still dominated by clinical/regulatory execution risk and potential future dilution, plus an ongoing securities class action. Several market-data fields (DCF/peers/insider/dividends feed) were unavailable in this run and are left as zeros.
Sentiment
weakSentiment is weak due to negative earnings and analyst revisions, with no clear short-term catalysts.
Near-term narrative is dominated by the Aug 10 Q2 print and follow-on sell-side estimate/price-target cuts, which skew perception bearish into the next few weeks. The media sentiment delta is indeterminate (14d analyzer returned no items; baseline sample is sparse), and the legal screen did not surface any regulator-confirmed investigation.
Technical
very weakTechnical analysis is unavailable due to indicator feed failures.
Technical analysis could not be completed because all TECHNICALMCP indicator and quote/chart calls failed with session-expired errors, so the technical read is unavailable and degraded.
You’re looking at 2026-08-19 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.